Industry News
Single-crystal diffractometer coming to UQ
Analytical instrumentation provider AXT will soon be installing a Synergy-S single crystal X-ray diffraction system, manufactured by Rigaku Oxford Diffraction (ROD), at The University of Queensland (UQ). [ + ]
Reversible 'master switch' for developmental genes discovered
Researchers have identified a reversible 'master switch' on most developmental genes in the common fruit fly, a powerful model organism for studying how human genes are organised and function. [ + ]
The secret role of epigenetics in antibody production
UK scientists have discovered a set of epigenetic marks and proteins that behave like genetic switches, controlling which genes contribute to making antibodies. [ + ]
Biomarkers — a silver bullet to cancer diagnosis and treatment, report
Fast-tracking biomarker research has the potential to transform cancer diagnosis and treatment, according to a report by the University of South Australia's Sansom Institute. [ + ]
Polymeric materials with molecular recognition capabilities
University of Leicester experts in association with the spin-off company MIP Diagnostics have developed polymeric materials with molecular recognition capabilities which hold the potential to outperform natural antibodies in various diagnostic applications. [ + ]
Izon Science appoints PsS as Australian distributor
Particle & Surface Sciences (PsS) has been appointed distributor for Izon Science products across Australia. [ + ]
Winners of the 2017 Metcalf Prizes announced
Stem cell researchers Mark Dawn and Jessica Mar have both received $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia. [ + ]
Australia and Sri Lanka partner for kidney research
Australian and Sri Lankan medical researchers have forged a new action plan to investigate the causes of a particular form of chronic kidney disease. [ + ]
Biotron compounds demonstrate antiviral activity against hep B
Biotron has announced that several of its compounds have demonstrated significant antiviral activity against hepatitis B (HBV) in recently completed preclinical studies. [ + ]
Prima BioMed announces positive data, pre-IND meeting for anticancer candidate
Prima BioMed has presented new data from a phase I clinical trial investigating eftilagimod alpha, its anticancer candidate, in combination with pembrolizumab in unresectable or metastatic melanoma patients. [ + ]
DNA testing could help improve mental health treatment
myDNA has conducted a national study into the mental health of Australians, revealing that two-thirds of people believe that improvements could be made to their medication. [ + ]
Shining a light on small diseased tissues
Singaporean researchers have created polymer nanoagents that can 'light up' tiny areas of diseased tissues that conventional methods fail to detect. [ + ]
Experts meet to discuss potential of particle therapy for cancer
Medical and health experts from across Australia and New Zealand recently convened in Adelaide to discuss the way forward for particle therapy in Australia. [ + ]
Fresh Science 2017 is coming to a pub near you
Fresh Science — an Australia-wide competition helping early-career researchers find, and then share, their stories of discovery — is now underway for 2017. [ + ]
Zero Childhood Cancer program comes to WA
The Zero Childhood Cancer program — said to be one of the world's most comprehensive child cancer personalised medicine studies — has finally reached Western Australia, seven weeks after its national launch. [ + ]